| RCKT Stock | | | USD 14.10 0.01 0.07% |
Rocket Pharmaceuticals financial indicator trend analysis is much more than just breaking down Rocket Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rocket Pharmaceuticals is a good investment. Please check the relationship between Rocket Pharmaceuticals Other Assets and its Total Assets accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rocket Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
For more information on how to buy Rocket Stock please use our
How to Invest in Rocket Pharmaceuticals guide.
Other Assets vs Total Assets
Other Assets vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Rocket Pharmaceuticals Other Assets account and
Total Assets. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Rocket Pharmaceuticals' Other Assets and Total Assets is -0.18. Overlapping area represents the amount of variation of Other Assets that can explain the historical movement of Total Assets in the same time period over historical financial statements of Rocket Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Rocket Pharmaceuticals' Other Assets and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Assets of Rocket Pharmaceuticals are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Other Assets i.e., Rocket Pharmaceuticals' Other Assets and Total Assets go up and down completely randomly.
Correlation Coefficient | -0.18 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Other Assets
Total Assets
Total assets refers to the total amount of Rocket Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Rocket Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Rocket Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rocket Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rocket Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
For more information on how to buy Rocket Stock please use our
How to Invest in Rocket Pharmaceuticals guide.At this time, Rocket Pharmaceuticals'
Selling General Administrative is comparatively stable compared to the past year.
Enterprise Value is likely to gain to about 2.6
B in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 203.6
M in 2024.
Rocket Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Rocket Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Rocket Pharmaceuticals fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Rocket Stock Analysis
When running Rocket Pharmaceuticals' price analysis, check to
measure Rocket Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rocket Pharmaceuticals is operating at the current time. Most of Rocket Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Rocket Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rocket Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rocket Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.